Submitted for publication July 8, 1991 ing and inflammation, then a rational basis for the design and application ofpharmacologic modulators of cell behavior to augment or mitigate wound contraction (as appropriate for the nature of the wound being managed) would be available. The model proposed here is a first attempt in that direction. A preponderance of evidence implicates fibroblastic cells as the primary force driving wound contraction [3J. However, the signals which determine the spatial and temporal distribution of fibroblastic cells in and around a wound, as well the factors which govern the magnitude of force transmitted by the cells to local extracellular matrix (ECM) fibers, are poorly understood. These .
of the locus of cell force during wound contraction for example, the "picture frame blastic cells pull .' in from the wound edge, and the "pull" where fibroblastic cells already within ate a tension which causes the inward movement wound boundary. Even the nature of the cell force been debated [5] : the "contraction force" with the hypothesized shortening of the entire cell l. INTRODUCTION "traction force" podal activity of a cultured fibroblast [7] . The mechanism by which fibroblasts and/or cause wound contraction is still an open question. Fortunately, the modeling approach described here is sufficiently abstract to accommodate both mechanisms (although he re we refer to the operative force solely as traction force, reflecting our bias, and use "fibroblast" to mean any fibroblastic cell exerting traction). Nonetheless, the traction force which presumably allows a fibroblast to migrate from the surrounding dermis into the developing granulation tissue at the same time causes some local reorganization ofECM fibers. This fiber reorganization, in turn, causes a local deformation of the ECM, and the macroscopic manifestation of all of the local deformations due to the traction forces exerted by all the fibroblasts involved in wound healing is wound contraction. Of course, other forces, such as viscous, elastic, and osmotic forces, also contribute to the actual rate and extent of wound contraction.
Wound contraction, the centripetal movement of the wound boundary and adjacent uninjured skin toward the wound center, is a hallmark ofhealing full-thickness cutaneous wounds [1] . There is strong motivation for understanding the interplay between the complex cellular, biochemical, and biomechanical phenomena which result in wound contraction, since it can be a beneficial or deleterious consequence of wound healing [2] . If a validated predictive model of wound healing were developed, one which accounted for the salient phenomena and provided a framework for accommodating the emerging understanding of the relationship between wound healTo whom correspondence should be addressed. 233 0022-4804/93 $4.00 Copyright @ 1993 by Academic Press, lnc. All rights of reproduction in any form reserved. tially independent of both the excised wound afea and the wound geometry for the limited cases studied (Table  1 ). The majar difference in the two wound geometries studied is associated with Ao, with the immediate expansion of square wounds being considerably greater than that of circular wounds ofthe same excised afea, leading to a larger Ao. Wound contraction in humans is algo characterized by the lag and exponential phases [9] although there are no data to prove the same conclusions regarding the independence of Af and kc from initial wound afea and geometry. These characteristic phases provide a basis for validation of any mathematical model of the dynamics of wound contraction. It is appropriate that the mathematical model be abstract in the sense of omitting uncertain details as \Ve 11 as flexible in the sense of being able to accommodate fundamentally different cell biology and more complicated biomechanics when they are postulated to be of significance. The model used in this work, based onthe continuum modelproposedby G. F. Oster, J. D. Murray, and their colleagues [11, 12] , possesses both ofthese features. It accounts for known cell functions, such as migration and mitosis, and the coupling of cell traction forces to the mechanical state of the ECM. This coupling leads to a predicted traction-induced deformation of the ECM. In this paper, we examine predictions of contraction for an idealized dermal wound using extensions of the Oster-Murray model which incorporate salient features of wound healing suggested above and expanded upon below. Our main objective here is to provide a framework for understanding how known and speculated fibroblast functions are orchestrated with other cellular, biochemical, and biomechanical events in wound healing to give rise to contraction. Our primar)' criterion of whether a particular set of fibroblast functions, ECM properties, and wound healing events is sufficient is qualitative consistency with the contraction curve typified in Fig. 1 . The number of sets which could be considered is quite large given the complexity of the wound healing response; therefore our survey cannot be comprehensive. Our strategy has been to examine a "base model" consisting of a minimal set upon which there seems to be general agreement (although not necessarily agreement on how they are modeled). Given that. the base model does not yield a contraction curve qualitatively consistent with Fig. 1 , extensions of the base model are made by incorporating additional fibroblast functions, ECM properties, and wound healing events and then checking for consistency with Fig. 1 . In addition to identifying those sets which meet the criterion, the predictive use of the model is demonst:rated by suggesting how modification of fibroblast functions enhances or diminishes the rate and extent of contraction, whichever is desired for managing a particular dermal wound. A full description of this work, including details of the mathematical model and its numerical analysis, is found in Tranquillo and Murray [13] . A plot ofthe wound afea normalized to the excised afea for a full-thickness rat wound (Fig. 1 of McGrath and Simon [10] ). Ao is the wound afea when contraction begins, Af is the afea remaining aftercontraction is completed, andA. = Ao -Afis the contracted afea. See text for details.
1
Wounds are not amenable to detailed quantitative study', and almost all such studies conducted to date have be en performed in animal models rather than human subjects. Whereas up to 100% of an animal wound afea may be closed by contraction owing to the presence of the panniculus carnosus, this value is considerably les s in humans, for example, 20-40% of postexcisional wound afeas ofthe forearm [8, 9] (the balance ofwound closure is attributable to reepithelialization over the granulation tissue). Not~'ithstanding this anatomical difference, it is generally believed that the underlying mechanisms are similar, and there are several quantitative studies based on animal wounds addressing the long-standing controversy of what type of wound clases the fastest. This is typically accomplished by measuring wound afea following the creation of an excisional wound, using tattoo marks to delineate the wound boundary and distinguish contraction from reepithelialization. McGrath and Simon [10] definitively showed that the contracting phase of excised dermal wounds on rats could be described with the simple exponential dependence on time
1 ': ti where Ao is the wound are a when contraction begins, Af is the area remaining after contraction is completed, both areas being scaled to the excised area, and he is the contraction rate constant. Excisional wounds undergo an immediate expansion, exhibit a "plateau" or "lag" phase of several days, and then exhibit the exponential contracting phase described by (1), which occurs on the arder ofweeks (Fig. 1 ). Af and he were found to be essen- The general features ofthe Oster-Murray model from which the base model for dermal wound contraction is formulated have been described at length elsewhere [11, 12] . Only a brief summary is given here with emphasis on considerations particular to wound healing and contraction. General modeling and analysis issues which apply to all model extensions presented in Section III are al so discussed in this section. Since we are concerned only with wound contraction here, we do not. consider the subsequent phases of wound healing, and assuming wound contraction is not significantly influenced by reepithelialization, we neglect the latter as well [14] . and myofibroblast phenot)rpes during the course of wound healing, which vary with respect to their migration, biosynthetic activities, and traction force capacity [3) . In this base model, however, we consider only a single population of fibroblasts exerting a constant traction force. Inflammatory, immune cells, and endothelial cells algo exhibit transient appearances in the granulation tissue and adjacent dermis. In several extensions of the base model, an implicit account is made for the speculated role of wound macrophages in releasing diffusible bioactive mediators which modulate fibroblast behavior (migration, mitosis, and traction force) at the wound site by postulating that a concentration gradient of such a mediator exists during the course of wound contraction. However, no account is made of the other majar cell type believed to significantly influence the wound healing process, the endothelial cell, which through the process of angiogenesis causes granul.ation tissue to be vascularized, thus influencing the concentrations of metabolic nutrients for fibroblasts. Instead of attempting to include angiogenesis in this first-generation model, we assume that wound contraction can be described to a first approximation without its inclusion; i.e., angiogenesis is assumed to proceed such that there are no limitations of oxygen and other blood-derived nutrients which would modulate the fibroblast responses. Note that any simplifying assumption can be appropriately modified where reliable modeling can be made.
The second simplification means that the variable p represents the collective fibrous network of both the wound ECM and the surrounding dermis (i.e., the total concentration of the ECM irrespective of composition and, therefore, of location). In reality, extensive modification of the wound ECM composition occurs during wound healing, the initial fibrin clot transforming into dynamic granulation tissue with time-varying percentages of collagen, fibronectin, hyaluronic acid, and other proteoglycans and glycosaminoglycans [15, 16) , all of which are synthesized by infiltrating cells and in turn likely influence their behavior in a concentration-dependent manner. Consistent with the abstraction embodied in the definition of p is the assumption that the
Model Formulation
In the formulation of the base model and all of its extensions, there are only three variables: the fibroblast concentration, n, the ECM concentration, p, and the displacement vector for the fibroblastjECM composite, U,2 all ofwhich are functions oftime, t, and spatial position, x. The current formulation reflects several significant simplifications which are consistent with the chosen degree of abstraction for the model at present: dynamics associated with migration and mitosis of fibroblasts alone are described explicitly (neglecting other cell types at this point), dynamics associated with movement and synthesis of the collective ECM are described (rather than for its constitutive components), and macroscopic stresses developed in the ECM associated with fibroblasts distributed throughout exerting traction forces are described ("coarse graining" of the point forces exerted by individual cells on individual ECM fibers). We briefly discuss these simplifications next.
The first simplification may be the most severe. Fibroblasts appear to transform between dermal fibroblast Wound Space (rapidly ¡Oled -rKlrin ciot) rheological properties of the ,..'ound ECM and surrounding dermis are the same. This is algo a gross, but appropriate, assumption, given that kno\\'ledge of granulation tissue rheology is virtually nonexistent. Also consistent is the notion that "direct synthesis" of fibrous network is meaningful in the context of the model; i.e., no explicit account is made for the complex transport and assembly steps of collagen and other ECM molecules.
The final simplification which makes account of traction forres exerted by cells on the ECM in which they reside as macroscopic "active stress" is the crux of the Oster-Murray modeling approach. As indicated earlier, details of how the cells generate and transmit motility forces which create this traction stress are unnecessary in this continuum formulation. The modeling of this traction stress is discussed further below.
A complete discussion of the base model assumptions and associated model parameters and equations is given in the Appendix. In summary, the base model assumes the following cell and ECM properties: fibroblasts random migration, passive convection (with ECM), logistic growth ECM passive convection cell/ECM composite simple viscoelastic material containing traction-exerting cells and with elastic subdermal attachments.
The equation which defines how u varíes with time and position is based on a balance of the forces assumed to be acting on the cell/ECM composite, which we state above. The key term in the force balance is that which accounts for traction-exerting cells distributed in the ECM, since in this model an imbalance of traction force is the driving force for contraction. We assume that the traction force acts isotropically, like a pressure, with magnitude proportional to the product n' p (implying a rapid equilibrium of cell pseudopod-ECM fiber anchorage interactions or receptor-mediated adhesions), where the proportionality factor, 7, reftects the traction stress generated per unit cell and ECM concentrations. To accommodate the in vitro observation of contact inhibition of motility [17] and, therefore, of traction force generation, 7 is taken to be a monotonic decreasing function of cell concentration, specifically 7 = 70/(1 + Xn2). This states that if the local cell concentration increases, all else being equal, the traction exerted by each cell in the locale decreases. The traction parameter 70 is a measure of the traction exerted by a cell on the local ECM in the absence of contact inhibition, which is measured by X. The functional forro of 7 is an open question, as is its validity for fibroblasts in vivo. lndeed, Gabbiani and coworkers noted that myofibroblasts possess numerous intercellular gap junctions and desmosomes at high cell concentrations which may act to synchronize and possibly enhance rather than inhibit traction force [18] . AIternative functional forms for T can easily be assessed within the framework of this modelo
To compare predictions of this base model and the extensions that follow with the results of McGrath and Simon [10] for contraction of full-thickness excisional wounds, the initial state of the model wound is taken to coincide with the state ofthe experimental wound following the immediate expansion phase (e.g., A = 1.35 at t = O in Fig. 1 is normalized to A = 1 at t = O in the model). ECM, devoid of fibroblasts, is assumed to be present in the wound initially; an accurate assumption gi,en the rapid formation of the fibrin clot. Furthermore, the ECM concentration in the wound is assumed to be the same initially as the dermis outside the wound boundary, defined as x = L, with value Po (x = O defines the wound center and L is the characteristic linear dimension of the wound). The wound is considered to be suitably isolated so that the surrounding dermis can be approximated as an "infinite medium" (equivalently, there are no "boundary effects"). This implies that variables should as sume values characteristic of uninjured dermis sufficiently far from the wound: p = Po, n = N (the maximum cell concentration in logistic growth), u = O (no displacement). These conditions for a "one-space-dimension" model wound (see below) are illustrated in Fig.  2 along with a summary of the model assumptions.
Two wound geometries are considered here, a linear wound, which is consistent with long parallel wound boundaries, and a circular wound. We assume that one space dimension applies, where variables depend only on one spatial coordinate, linear or radial (i.e., no dependence ofvariables on vertical position). This ássumption is generally not true; however, our modeling of subdermal attachment of the ECM (see the Appendix) makes an approximate account for the vertical dimension. Note that for a one-space-dimension model, the displacement vector u becomes simply a scalar variable, u (here, linear or radial displacement depending on linear or radial distance from the wound center, respectively).
Alodel Predictiol1S
the unperturbed state (A -1) rather than any contraction of the wound boundary inward (A < 1). It thus seems that the base model set of fibroblast and ECM properties, which we consider to be a minimal set ofproperties applicable for dermal wound healing, is inadequate for simulating wound contraction.
III. MODEL EXTENSIONS
AII extensions of the base model add to the fibroblast functions, ECM properties, and wound healing events assumed for the base modelo Except for the "ECM biosynthesis" extension, they are motivated by the widely recognized infiuence of infiammation-derived biochemical mediators on fibroblast functions. Although the prevailing consensus is that wound contraction is predominantly regulated by the infiammatory phase which precedes and overlaps it, positive feedback intrinsic to the fibroblast response (to the initial infiammatory stimulus) may eventually be the regulatory determinant. Such feedback, leading to enhanced fibroblast accumulation in the wound, might be both biochemical and biomechanical (see Discussion). We have chosen he re to circumvent the added complexity of a variable concentration field oí the mediator and simply assume that a steady-state concentration exponentially decreasing away from the wound center exists ayer the time-course of contraction.
Details of the numerical solution of the modeling equations are found in Tranquillo and Murray [13] . A nonlinear least squares regression fit of predicted values of the normalized wound afea ayer a series of times, A(tj), was performed to determine optimal values for the parameters defining (1): Ao, Af, and k, the dimensionless contraction late constant (k = k"L2j:IJ, where k" is the dimensional contraction late constant and :IJ is the cell "diffusion coefficient" measuring random migration). There is variability in the goodness of fit among different parameter sets, indicating that the exponential fit is more or les s satisfactory depending on the parameter values. AIso, the regression value for k can be quite sensitive to the number of included A(tj) points at long times when the steady state is approached (i.e., when variables no longer change with time). Most of the fits underlying the parametric sensitivity plots (e.g., Fig. 4 ) are at least as satisfactory as the one presented in Fig.  3d ; however, variations in k of up to :tO.1 can be associated with different time cutoffs.
The model variables are made dimensionless by choosing appropriate scaling factors, as shown below:
t t = L27:15
A. Traction Variation
Among the various ways that an infiammatory mediator could infiuence the behavioral properties of fibroblasts, it has been suggested that fibroblasts may transform into traction-enhanced myofibroblasts around the wound due to some infiammation-derived growth factor [3] . A simple alternative to modeling the population dynamics of the myofibroblasts explicitly is to make TO' measuring fibroblast traction, an increasing function of the mediator concentration, c. Thus, as cells approach the wound center, they encounter a greater mediator concentration (by assumption, above) and exert a greater traction. We assume for illustration that T o has a saturable dependence on c,
(all variables and parameters are dimensionless hereafter, although tildes are omitted). There are several advantages to doing this: the dimensionless variables do not have units and take on values of arder one. Also, when the variables in the governing model equations are made dimensionless, five dimensionless parameter groupings arise (see the Appendix). Since there is a scarcity of data currently available from which to define values for the 10 model parameters appearing in the base model, leaving a very large number ofparameter combinations for characterization, another advantage of scaling the variables is that only five parameter groups must be assigned values. Furthermore, four ofthe groups measure the relative importance of competing phenomena: ro represents the ratio of characteristic times for fibroblast repopulation of the wound by random migration across the wound space to that by proliferation, JL a characteristic ratio of viscous force to elastic force acting in the wound, TO the ratio oftraction force to ECM elastic force, and s the ratio of subdermal elastic force to ECM elastic force. The values used for the dimensionless groups in the results presented are mostly of arder one, which means that one phenomena is not dominating the other.
We did not observe predictions of the base model consistent with features of a contracting wound (Fig. 1) , at least for the parameter combinations examined. Typically, there is a slight expansion of the wound boundary outward (A > 1) followed by relaxation inward back to where Tf is a traction force enhancement coefficient. By prescribing c to be 1 at the wound center, TO increases from a value characteristic of the uninjured dermis, TO' far from the wound to a maximum value 50. Tf % greater at the wound center.
An example of the model predictions is given in (Table 2) . Accounting íor the scaling dependence of k on L (since (1) in terms oí dimensionless time is used to fit the predicted A(t;) values), the expected value oí k, ií kc is indeed independent oí geometry, is k = 0.222. Thus, in the case oí a linear wound, the model predicts a slight dependence of kc on initial wound area (relative change in kc, ~kc = -12%), atleastíorthiscombinationofparame-ters (a change oí this magnitude may not be significant given the variability in k associated with an imperfect exponential fit which was noted earlier). This is consistent with the lack oí dependence found by McGrath and giman for a square wound with one-halí the initial area (Table 1 ; ~kc = +18% was determined not statistically significant, nor were any oí their values íor ~kc or Mr).
For a circular wound with the same linear dimension as the linear wound (i.e., same diameter as width) the model predicts k = 0.952, quite clase to the values predicted for the linear wound (Table 2 : ~kc = -4.6%), in accord with McGrath and Simon's finding concerning and proliferation is seen in Fig. 3a . The evolution of the cell/ECM composite to a contracted steady state (cf. a contracture) is apparent from the simulated time-course of displacing tattoo marks in Fig. 3e derived from the displacement profiles in Fig. 3b (note that u(x, t) < O means the material point located at position x at time t has displaced toward the wound center from its initial position, and conversely for u(x, t) > O). Associated with the contraction is an increase in the ECM concentration (p> 1) in the wound (Fig. 3c) . The plot ofthe wound are a (based on the location of the wound margin) over time in Fig. 3d is qualitatively consistent with the data in Fig. 1 , suggesting that the fibroblast-ECM-inflammatory mediator mechanisms of this scenario can interact to yield the empirical exponential fit of (1).
Given that these results are in accord with the simple criterion of contraction, it is of interest to determine how other parameters of the model affect the qualitative and quantitative features ofthe predictions for this case. The dependence of the dimensionless contraction late constant, k, and the wound afea remaining after contraction is completed, Af, on the traction force enhancement factor, Tf, is presented in Fig. 4 . Af decreases for increasing Tf (Fig. 4a) , as expected, since a greater traction exerted per cell suggests an increased final extent of contraction. Figure 4b indicates only a weak dependence of k on Tf over the range investigated.
FIG.3.
Representative predictions of tbe "traction variation" extension for Tr = 2 and a linear wound: (a) fibroblast concentration, n, (b) displacement of the cell/ECM composite, u, and (c) ECM concentration, p, are plotted versus distance from the wound center for a series of times after wounding. x = O is the wound center and x = 1 is the initiallocation ofthe wound boundary. Since the profiles are symmetrical about x = O, only the results for x ~ O are shown. The traction profile associated with the inflammatory mediator gradient is indicated (not to scale; actual range is 0.5-1.0; see [3] ). In (d) the relative wound are a (actual area normalized to the initial area following immediate expansion) plotted as a function of time is described by the continuous curve (A > 1 is associated with wound expansion; A < 1 is associated with wound contraction). The dashed line is the nonlinear least squares regression fit of the numerical data A(l, tJ to tbe exponential forro of (1) investigated by McGrath and Simon [10] . In (e) the movement oftattoo marks located across the wound and adjacent dermis is simulated for a series of times over the course of contraction. Parameter values are r = 1, Jl. = 1, s = 1, TO = 0.5, ~ = 1. See text for discussion.~"~; .k is a dimensionless form of kc; kpM is the predicted value oí k assuming k" is const~nt. knowledge, in vitro data from cultured fibroblasts in tissue-equivalent collagen gels. Here we assume for illustration that fibroblasts will proliferate to a higher maximuro cell concentration in the presence of a growth factor and take the functional dependence of N on c again to be a simple saturable dependence as was done for T in (3) (defining Nf analogously to Tf).
To meet the A < 1 contraction criterion, it was necessary to reduce X, the parameter measuring the extent of contact inhibition of traction, from the value 1 assumed until now to 0.1 (inhibition now does not occur until higher cell concentrations). To facilitate the computations, .IL was increased from 1 to 10 (ECM viscous forces are now an arder of magnitude greater than ECM elastic forces). Otherwise, the parameter values are as for the previous cases (note that Tf = O applies here, i.e., no variable traction). As seen in Fig. 5 the profiles are distinctl:-' different from the "traction variation" extension,. notably the increased cell concentration in the wound. AIso, at least for these parameter values, the point of maximuro displacement toward the wound center occurs outside the wound (at x ~ 2.5) rather than near the initial location ofthe wound margin (x = 1) (cf. Fig. 3b ). Unlike the traction variation results, the dependence of Af on the varied parameter (here, N J is not monotonic; rather an optimal Nf (~5) exists for minimum Af (Fig. 6a) . Thiĩ s due to inhibition of traction force in the wound as tht:' cell concentration increases (relative to X) with increasing Nf. AIso, k now shows a significant dependence 011 the varied parameter, N f. The increase in k with increasing Nf reflects the more rapid fibroblast repopulation 01' the wound (cf. Figs. 3a and 5a ). This is due to a greater cell growth late in the direction of the wound associateo with increasing N in the lo gis tic growth late law. the independence of kc from wound geometry (Table 1 : Ákc = -12%). Although comparison data are not available, model predictions were obtained for a circular wound with initial afea Ao/2 (i.e., L/21/2), where k = 0.422 (vs prediction ofO.455, Ákc = -7.2%), and for initi al afea 2Ao (i.e., L. 21/2), where k = 2.12 (vs prediction of 1.82, .:lkc = + 16%). Thus, the model is consistent with their conclusion concerning independence of kc from Ao for circular as well as linear geometry.
Comparisons of the wound afea are more difficult to interpret since the values of Ar observed by McGrath and giman are much smaller than those predicted by our model under the small strain (therefore, small displacement, small contraction) assumption implicit in our model equations (see the Appendix). Comparing values of LlAr, the relative change in final wound afea, the model predictions agree with McGrath and Simon's conclusion that the extent of contraction is independent of initial wound size; agreement does not exist for LlAc values, the relative change in contracted afea, the model predictions showing a strong dependence on initial wound size.
It is reasonable to question whether their finding that kc and Ar are independent of initial wound afea, based on square and circular wounds, should, in fact, apply to linear wounds as well, since now the geometries are fundamentally different. Our model predictions suggest so, but this remains to be verified.
B. Growth Variation
Given the feasibility of topical application of patientderived growth factors to cutaneous wounds [19] , it is of interest to understand the consequences of a concentration gradient of a single growth factor around the wound site which affects the mitotic characteristics of infiltrating fibroblasts. Unfortunately, there are no in vivo data from which to deduce how the parameters of the assumed logistic growth rate (see the Appendix), r and N, may depend on growth factor concentration, nor, to our C. ChemotaxÍ8
Fibroblasts are considered to be chemotactic to a number offactors which are generated atthe wound site (i.e.. factors, and proteolytic ECM fragments [20, 21] ), and it is typically assumed that chemotaxis is an important mechanism by which fibroblasts, as well as most other cells involved in wound healing, localize in the wound. Here we as sume the simplest description of chemotaxis, based on adding a chemotactic term to the random migration term in the cell conservation equation defining n (see the Appendix). The chemotactic term is proportional to the product of the cell concentration, the spati al gradient of the chemotactic factor concentration, and the chemotaxis coefficient, x, which measures the directional bias exhibited by a cell in a chemotactic gradient (the steady chemotactic factor concentration profile is taken to be the same as that for c previously used for the traction variation and "growth variation" extensions). Recognizing that chemotaxis serves as a mechanism oí fibroblast accumulation, it is expected that these results would share similarities with the growth variation extension, for the same reasons (Fig. 7) . Over the range oí X examined (x = 0-1.2), the dependencies oí k and Af on x are qualitatively similar to those for T f (Fig.  4) . Although dependencies similar to those for Nf (Fig. 6) appear for larger values of x (greater directed migration), the small strain assumption becomes more violated and the results less valido
In passing, we note that fibroblasts resident in the dermis are believed to be essentially nonmigrating (zero speed) in the absence of any stimulation, so chemotactic factors typically increase the speed of movement (orthokinesis) as well as bias the direction of movement (chemotaxis). An account for orthokinesis requires yet another migration term, but the theoretical consequences are well known: if speed increases only as a cell migrates toward the wound, orthokinesis will counteract the accumulation of fibroblasts in the wound associated with chemotaxis; if speed increases then decreases, it will enhance the accumulation where the speed passes through its maximum value.
D. ECM Biosynthesis
Here, the base model is extended to include an ECM generation term to account for the extensive deposition of collagen and other ECM macromolecules by fibro- blasts in the granulation tissue. Since the regulation of this process is poorly understood, a particular functional dependence of the net ECM generation late on the model variables (n, u, p, and c) cannot be independently justified. We assume, solely for the purpose of illustration here, that this late is proportional to that of fibroblast proliferation (i.e., a logistic growth-type late: bn(l -n», so that there is ECM accumulation until cells repopulate the wound (n -1). Although this late forro yields a contracted steady state (Fig. 8 ) without having to invoke the influence of an inflammatory mediator, the fact that p attains a steady state on the time scale of wound contraction is not consistent with the observation that collagen continues to accumulate for extended periods after completion of wound contraction. A greater understanding of ECM regulation in wound healing is needed to guide any future proposition of realistic late forros for ECM generation.
IV. DISCUSSION
This work marks an initial effort aimed at elucidating how the cellular, biochemical, and biomechanical phenomena known or speculated in the dermal wound healing process are orchestrated to give rige to wound contraction. Given the complexity of the phenomena, compounded by the uncertainty of many regulatory points, the strategy that we have adopted is to establish a continuum model framework based on a set of cell functions and ECM properties which seem intrinsic to any scenario of wound contraction: fibroblasts repopulate the wound ECM by a combination of migration and proliferation and, in the course of exerting traction force s associated with their motility, deform the local ECM, which has a viscoelastic character. Numerical solutions of the equations describing a base model where cell and ECM properties do not vary with time or position show only~J ,; j an expansion of the wound boundary followed by relaxation to its initial position as fibroblasts repopulate the wound. Thus, the base model, which takes no account of the infiuence of bioactive factors generated from the infiammatory processes, appears inadequate to explain wound contraction. Interestingly, infiammation and wound contraction are both notably absent in early gestation fetal wound healing ¡ '22] . Several scenarios suggested by the possible role of infiammation-derived mediators of fibroblast behavior in the wound healing response were examined by appropriate extension of the base modelo Upon postulating a steady concentration gradient of an infiammatory factor emanating from the wound during the time-course of contraction, model predictions are qualitatively consistent with wound contraction for the cases where the factor enhances any of the following fibroblast properties: traction force, maximum concentration in the ECM, and chemotaxis. As a quantitative test of the model, the predicted variation of uncontracted wound afea with time was fit with the empirical, exponential rate contraction law (1) for characterization in terms of the dimensionless contraction rate constant, k, and the final uncontracted are a relative to the initial wound afea, Af. In accord with the experimental findings of McGrath and Simon [10] , k and Af are only weakly dependent on both wound geometry (based, however, only on a comparison of linear and circular wounds of the same characteristic dimension) and initial afea (based on a comparison of wounds with half and double the initial afea) for the traction variation extension of the base model, at least for the parameter values tested. In this extension, the traction force parameter is a saturating function of the local concentration of the inftammatory mediator.
The model predictions concerning the occurrence and extent ofwound contraction (i.e., the parametric dependencies of AJ are intuitively obvious based on the fact that in this model, wound contraction is driven by an imbalance of traction force. Within the context of the current model, that is possible if (i) the fibroblast concentration in the wound is greater than that outside the wound (but not so great that contact inhibition, if any, is significant), each cell generating the same traction (e.g., the growth variation and "chemotaxis" extensions), or (ii) the fibroblast concentration in the wound is the same as that outside the wound, but cells closer to the wound center generate more traction (e.g., the traction variation and ECM biosynthesis extensions). These assertions are consistent with the classical "pull" hypothesis of wound contraction and follow directly from the form of the traction force term in the mechanical force balance, traction force oc n' p at low values of n (n and p are the fibroblast and ECM concentrations, respectively), which drives the displacement of the cell/ECM composite. They are algo supported by the parametric dependencies presented for Ar. Clearly, the functional form of the traction force term is critical to the model predictions and needs to be justified theoretically (e.g., from a microstructural model of cell-fiber mechanical interactions) and experimentally (e.g., from force measurements of fibroblasts cultured in tissue-equivalent collagen gels [23, 24] ).
A number of unsatisfactory aspects of the base model and its extensions are discussed in their respective sections. The prescription of the mediator concentration gradient in lieu of it being autonomously determined from a mathematical model of infiammation affords great simplicity but has undesirable consequences: it creates some ambiguity in comparing the results for the linear and circular wounds, because identical infiammatory mechanisms will not generally give rige to the same gradient in different geometries. More seriously, besides circumventing the question oí the causal factors and ultimate regulatory control of wound contraction, it does not allow for the investigation oí potentially important biochemical feedback effects due to autocrine íactors which infiltrating fibroblasts probably release. AIso, it imposes constraints on the predicted rate of contraction, if in reality the gradient is dissipating beíore contraction logies do not involve a prominent inflammatory component. For example, alignment of ECM fibers in and around the wound, due initially to platelet contraction of the fibrin clot and subsequently due to wound contraction, may be a mechanism leadingto localizationoffibroblasts in the wound via contact guidance and haptotaxis, as we investigate elsewhere [24] . Of course, a more realistic constitutive stress-strain relation for the dermis and granulation tissue, in particular one that admits large strains and accounts for the dependence of rheological parameters on the composition and orientation state of the ECM fiber network, is a necessary refinement for clinical applicability. The complex evolution ofthe composition and structure of granulation tissue has implications not only for the forro of the stress-stram relation and parameter values defined therein, but algo for the role of the traction stress termo We have illustrated this in a contrived way (ECM biosynthesis extension) by allowing for the generation of ECM during the process of wound repopulation by fibroblasts, resulting in increased p, which by virtue of the assumed functional forro of the traction force term drives wound contrac-ĩ s complete. To investigate ibis consequence further, we prescribed dissipation ofthe mediator gradient to simulate the resolution of inftammation by prescribing that the mediator concentration at each point in space decay exponentially with time (c oc e t). Results for the illustrative traction variation case of Fig. 3 for different values ofthe temporal decay rate constant, "', are presented in Fig. 9 (the time required for c to decay 95% of its initial value at any point in the gradient is 30, 3, 0.3 for '" equal to 0.1, 1, 10, respectively). Note that in each case, a contracted steady state (cf. a contracture) results even after the mediator gradient which elicited the contraction has dissipated. Obviously, both the kinetics (k) and the final extent of contraction (Ar) can vary with the rate oí gradient dissipation ("').
We have concentrated here on some scenarios by which wound contraction could result from the modulation oí a fibroblast function by an inftammatory mediator. However, that is only part of a much broader picture. There are a number of biomechanical as opposed to biochemical regulatory mechanisms which are worth considering, necessarily so, since a variety of fibrotic patho- Inclusion of mechanisms which model the evolution of granulation tissue composition and structure more realistically would allow the contribution of this effect to be understood better and possibly provide a basis for using the model to consider the occurrence of hypertrophic scars and keloids and their relationship to wound contraction. Another class of biomechanical mechanisms relates to the probable modulation of fibroblast metabolism by stress and strain in the deforming ECM. There are many examples recently documented for altered metabolism of cells cultured on substrata which are externally deformed or subject to fluid shear, which suggests that fibroblast functions may be modulated during wound contraction. Finally, electrical fields generated intrinsically within the wound and applied externally may affect various aspects of the cell and tissue response [25] .
In summary, there are many scenarios for wound contraction which can be considered given the complexity of the wound healing process. This "mechanocellular" modeling approach offers a possibility of considering the effects of known and speculated cell proliferation, migration, and traction responses and ECM rheological properties individually as well as collectively. An improved uriderstanding of how these effects are interrelated through modeling, which will be promoted by applying this modeling approach to a novel in vitro wound healing and contraction assay [24, 26] , should lead to new therapies for controlling wound contraction and optimizing the wound healing response.
The convective term is a passive contribution to the net cell flux due to any time-dependent displacement of the cell/ECM composite. This contribution occurs irrespective of the assumed modes of active cell migration and simply states that if a force imbalance causes the ECM to deform, resident cells will be carried along with the deforming ECM. For the base model we assume only that fibroblasts migrate randomly ("cell" will mean fibroblast hereafter). We take the cellular equivalent of Fick's Law for modeling random migration, as demonstrated for fibroblasts on substrata [28] and other cell types in isotropic collagen gels in vitro [29] , involving a cell diffusion coefficient, :IJ (\\'hen migration is random, :IJ is proportional to the mean square cell displacement divided by time, for times much greater than the cell directional persistence time). A reasonable choice for modeling the net rate of cell proliferation (mitosis plus death) is the logistic gro\vth rate, which is consistent with data for cultured dermal fibroblasts in collagen gels [30] and myofibroblasts on substrata [31] , involving first-order growth rate constant r and maximum cell concentration N (In 2/r is the mínimum "doubling time" as the cells proliferate from an initial concentration much less than N' N is the concentration to which cells , will proliferate characteristic of the extracellular environment).
Given these assumptions and definitions, the mathematical forro of (A2) is
The three variables of the model satisfy fundamental conservation laws: species conservation, yielding equations describing n and p, and linear momentum conserIn the chemotaxis case oí Section IIIC, the chemotactic flux term \7. xn\7c is added to the right side oí (A3) [32] .
For the ECM conservation equation, (Al) states that terms reflecting net flux and net generation of ECM must be specified. Since the ECM is modeled as an aggregate of networked fibers, there is only a convective component to its flux (i.e., the fiber network does not diffuse). Fibroblasts playa key, but incompletely understood, role in the regulated levels of collagen, fibronectin, and other constituents of the dermis and granulation tissue. However, to keep the base model as simple as possible, no generation term is included (see ECM Biosynthesis). In this case, the mathematical forro of (Al)is simply In the ECM biosynthesis case of Section IIID, the net generation rate bn(l -n) is added to the right sirle of (A4).
The momentum conservation equation expresses the requirement that the rate of accumulation of momentum in the control volume equal the net momentum flux through the boundaries ofthe control ,'olume associated with material flow and surface stresses plus the net rate of momentum generation within the control volume due to bodyforces. When inertial forces associated with acceleration of mass in the control volume are negligible, as is the case for celljECM mechanics, then the momentum conservation equation expresses t.hat the sum of all forces acting on the control volume in a specified direction must sum to zero. If the control ,'olume is taken to be a box with sides of area A, t.hen the following must hold in each of the three orthogonal directions:
viscosities, JIl and JI2, Young's modulus, E, and Poisson's ratio, v.
This stress-strain relation is modified heuristically to account for traction-exerting cells distributed in the ECM by adding a term which accounts for a resultant isotropic (traction) stress, as discussed under Model Formulation. Another force to be considered is the reaction force on the celljECM composite due to forces transmitted through attachments of the ECM to subdermal structures (e.g., muscle fasciae). For simplicity, we model this force as alinear, elastic, restoring body force measured by the elastic constant, s.
The linear stress-strain assumption applies only for sufficiently small strains. Furthermore, anisotropy associated with stress-induced fiber alignment is not admissible (this is to be distinguished from fiber alignment occurring local to a cell due to its traction structuring activity [36] , which is not relevant for this macroscopic description). Ho\\'ever, in wounds which exhibit significant contraction, strains are considerable andalignment of ECM fibers directed toward the wound center probably occurs. Thus, a strictly valid comparison of the model predictions can only be made with wounds exhibiting minimal contraction. The occurrence of osmotic forces which may develop in the wound space, particularly in the early stages of wound healing when hyaluronic acid is present in elevated concentration [16] , are neglected here, although they can be readily incorporated into the mechanical force balance.
Given these assumptions and definitions, the mathematical forro of (A5) is In our case, this represents a mechanical force balance between traction forces exerted by the cells and force s associated with the physicochemical properties of the ECM. Theconstitutive stress-strain relation for dermis, if one were available, would be quite complex [33] , and this must certainly also be true for granulation tissue. An accurate model of the dermis would also entail at least a "biphasic" description (aka poroviscoelastic), where mechanical force balances are applied to distinct fiber and "solution" (i.e., nonfiber) phases [34, 35] . Consistent with our modeling philosophy but with the los s of considerable generality, we describe the cell-free ECM in the base model and in all extensions as a homoge-.neous solid in which el as tic and viscous forces, varying linearly with strain and strain rate, respectively, can arise (recall that we make no rheological distinction between the dermis and granulation tissue at this stage). Even these simplifying assumptions do not uniquely define the constitutive stress-strain relation, and we choose a standard form which entails the shear and bulk where ~ =%<vu + VUT) = strain tensar, u = x -Xo = displacement vector, 8 = v. u = dilation.
The specific forms of the above equations for linear and circular wound geometries can be found in [13] . The five dimensionless parameter groupings which alise when the governing equations are made dimensionless using [2] 
where ti = (1 + v)(1 -2v)/(1 -v).
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